All Stories

  1. Editorial (Thematic Issue: Impact of Early Life Stress on Psychiatric Disorders: Searching New Biomarkers and Innovative Pharmacological Targets)
  2. Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats
  3. Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats
  4. Modulatory Activity of Soluble Beta Amyloid on HPA Axis Function in Rats
  5. Editorial (Thematic issue: Soluble Beta Amyloid in a Continuum from Physiology to Pathology: Searching the Determinants of its Effects and Designing New Pharmacological Treatments)
  6. An updated animal model capturing both the cognitive and emotional features of post-traumatic stress disorder (PTSD)
  7. Chronic nandrolone administration induces dysfunction of the reward pathway in rats
  8. Drugs of Abuse and Oxidative Stress in the Brain: From Animal Models to Human Evidence
  9. Carvacrol: From Ancient Flavoring to Neuromodulatory Agent
  10. Severe Life Stress and Oxidative Stress in the Brain: From Animal Models to Human Pathology
  11. Neuroendocrine Profile in a Rat Model of Psychosocial Stress: Relation to Oxidative Stress
  12. Brain Nerve Growth Factor Unbalance Induced by Anabolic Androgenic Steroids in Rats
  13. Neurochemical differences in two rat strains exposed to social isolation rearing
  14. The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats
  15. Neurochemical consequence of steroid abuse: Stanozolol-induced monoaminergic changes
  16. NOX2-deficiency prevents ketamine-induced behavioural and biochemical alterations in mice
  17. Involvement of the NADPH oxidase NOX2 in the development of behavioral and pathological alterations in isolated rats
  18. Involvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats
  19. Chapter 9 Developmental Exposure to Cannabinoids Causes Subtle and Enduring Neurofunctional Alterations
  20. Determination of dimethylarginine levels in rats using HILIC‐MS/MS: An in vivo microdialysis study
  21. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
  22. The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat
  23. Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor
  24. CHF2819: Pharmacological Profile of a Novel Acetylcholinesterase Inhibitor
  25. Prenatal low-level exposure to CO alters postnatal development of hippocampal nitric oxide synthase and haem-oxygenase activities in rats
  26. Effects of ENA713 and CHF2819, two anti-Alzheimer’s disease drugs, on rat amino acid levels
  27. Nitric Oxide Can Differentially Modulate Striatal Neurotransmitter Concentrations via Soluble Guanylate Cyclase and Peroxynitrite Formation
  28. In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus
  29. Modulation of striatal serotonin and metabolite levels by nitric oxide: An in vivo microdielysis study
  30. Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring
  31. Essential oils from fruits of three types of Thapsia villosa
  32. Intranigral GR-113808, a selective 5-HT4 receptor antagonist, attenuates morphine-stimulated dopamine release in the rat striatum
  33. Developmental Neurotoxicity of Carbon Monoxide
  34. Cholertic activity of Thapsia chem I, II, and III in rats: Comparison with terpenoid constituents and peppermint oil
  35. Choleretic Activity of some Typical Components of Essential Oils